Keywords: بکساروتن; Lymphatic transport; Prodrugs; Bexarotene; Retinoic acid; Chylomicron; Activated esters;
مقالات ISI بکساروتن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بکساروتن; Bexarotene; Amphiphilic prodrug; Nanovesicles; Anticancer activity;
Keywords: بکساروتن; Bexarotene; Alzheimer's disease; Beta-amyloid; Oligomers; Synaptic transmission; Behavior;
Keywords: بکساروتن; Bexarotene; Low HDL; Retinoids; Dyslipidemia;
Keywords: بکساروتن; Alzheimer's disease; Epilepsy; Bexarotene; Hyperexcitability;
Bexarotene protects against neurotoxicity partially through a PPARγ-dependent mechanism in mice following traumatic brain injury
Keywords: بکساروتن; Bexarotene; Traumatic brain injury; Neuron; Astrocyte; Microglia; Peroxisome proliferator-activated receptor gamma;
The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis
Keywords: بکساروتن; Cutaneous T-cell lymphoma; 9-cis UAB30; Bexarotene; SKP2; p27kip1; PSMA7;
DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators
Keywords: بکساروتن; Nuclear receptors; Liver X receptor; Alitretinoin; Bexarotene; SOSA;
Simple and sensitive HPLC-UV method for determination of bexarotene in rat plasma
Keywords: بکساروتن; Bexarotene; HPLC-UV; Preclinical pharmacokinetics; Rat plasma; Human plasma; Mouse plasma;
The long non-coding RNA Neat1 is an important mediator of the therapeutic effect of bexarotene on traumatic brain injury in mice
Keywords: بکساروتن; Bexarotene; RXR; lncRNA; Neat1; Pidd1; TBI;
Disfunción tiroidea y lipÃdica asociada a bexaroteno en el linfoma cutáneo de células T
Keywords: بکساروتن; Bexaroteno; Linfoma cutáneo de células T; Colesterol; Función tiroidea; Bexarotene; Cutaneous T-cell lymphoma; Cholesterol; Thyroid function;
Thyroid and lipidic dysfunction associated with bexarotene in cutaneous T-cell lymphoma
Keywords: بکساروتن; Bexarotene; Cutaneous T-cell lymphoma; Cholesterol; Thyroid functionBexaroteno; Linfoma cutáneo de células T; Colesterol; Función tiroidea
Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies
Keywords: بکساروتن; Differentiation; Acute myeloid leukemia; Myelodysplastic syndrome; Bexarotene; Entinostat;
Coadministration of VDR and RXR agonists synergistically alleviates atherosclerosis through inhibition of oxidative stress: An in vivo and in vitro study
Keywords: بکساروتن; 1,25(OH)2D3; Atherosclerosis; Bexarotene; Diabetic; Oxidative stress; Retinoid x receptor; Vitamin D receptor;
A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjects
Keywords: بکساروتن; Alzheimer's disease; Apolipoprotein E; β amyloid; Retinoid X receptor; Bexarotene
Retinoids and motor neuron disease: Potential role in amyotrophic lateral sclerosis
Keywords: بکساروتن; Amyotrophic lateral sclerosis; Bexarotene; Neurodegeneration; Retinoids; SOD1;
Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
Keywords: بکساروتن; Bexarotene; Brentuximab vedotin; Cutaneous T-cell lymphoma; Mycosis fungoides; Romidepsin; Sézary syndrome; Vorinostat;
RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment
Keywords: بکساروتن; Alzheimer's disease; APP/PS1 transgenic mice; mRNA-seq; ChIP; RXR; Bexarotene; Trem2; Tyrobp; Aβ phagocytosis;
The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma
Keywords: بکساروتن; Retinoids; Rexinoids; Bexarotene; Isotretinoin; Acitretin; Cutaneous T-cell lymphoma; Mycosis fungoides; Sézary syndrome;
Bexarotene prodrugs: Targeting through cleavage by NQO1 (DT-diaphorase)
Keywords: بکساروتن; Prodrugs; Parkinson’s disease; Alzheimer’s disease; dt diaphorase; Disease targeting; Bexarotene
Synthesis of a new fluorine-18-labeled bexarotene analogue for PET imaging of retinoid X receptor
Keywords: بکساروتن; 2-[18F]fluoro-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid; Bexarotene; Retinoid X receptor (RXR); Apolipoprotein E (APOE); Positron emission tomography (PET); Alzheimer's disease (AD); Cancer;
Systematic review of combination therapies for mycosis fungoides
Keywords: بکساروتن; Mycosis fungoides; Systematic review; Interferon-alpha; Bexarotene; Puva; Combination therapy;
Bexarotene nanocrystal—Oral and parenteral formulation development, characterization and pharmacokinetic evaluation
Keywords: بکساروتن; Bexarotene; Nanocrystals; Crystalline state; Dissolution rate; Parenteral administration; Pharmacokinetics
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
Keywords: بکساروتن; Cutaneous T-cell lymphoma; Panobinostat; Pan-deacetylase inhibitor; Mycosis fungoides; Sézary syndrome; Bexarotene;
Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations
Keywords: بکساروتن; Bexarotene; Cutaneous gamma/delta T-cell lymphoma; Subcutaneous panniculitis-like T-cell lymphoma
Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides
Keywords: بکساروتن; Bexarotene; Extracorporeal photopheresis; Interferon; Mycosis Fungoides; Sézary syndrome
Rational Clinical Trial Design in Cutaneous Lymphoma
Keywords: بکساروتن; Bexarotene; CTCL; Cutaneous T-cell lymphoma; Drug approval; Vorinostat;
Trasplante autólogo de progenitores hematopoyéticos seguido de bexaroteno oral en paciente con micosis fungoide avanzada
Keywords: بکساروتن; trasplante autólogo de precursores hematopoyéticos; bexaroteno; linfoma cutáneo de células T; micosis fungoide; autologous hematopoietic stem cell transplant; bexarotene; cutaneous T-cell lymphoma; mycosis fungoides;
Hipotiroidismo central y dislipemia mixta secundarios a tratamiento con bexaroteno
Keywords: بکساروتن; Ligando selectivo del receptor X retinoico; Hipotiroidismo central; Bexaroteno; Retinoid X receptor-selective ligands; Central hypothyroidism; Bexarotene;
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma
Keywords: بکساروتن; Cutaneous T-cell lymphoma; CTCL; Mycosis fungoides; Sezary syndrome; Bexarotene; Carmustine; PUVA; TSEB; Denileukin diftitox; Allogeneic transplant
Alteraciones endocrino-metabólicas inducidas por bexaroteno en el tratamiento del linfoma cutáneo de células T
Keywords: بکساروتن; Bexaroteno; Linfoma cutáneo de células T; Hipotiroidismo central; Hipertrigliceridemia; Bexarotene; Cutaneous T-cell lymphoma; Central hypothyroidism; Hypertriglyceridemia;
Tratamiento de linfomas cutáneos de células T con bexaroteno
Keywords: بکساروتن; linfoma cutáneo de células T; bexaroteno; tratamiento; cutaneous T-cell lymphoma; bexarotene; treatment;
Nonclassical Retinoids and Lung Carcinogenesis
Keywords: بکساروتن; Bexarotene; Combination therapy; EGFR inhibitors; Rexinoids; Targeted therapy;
The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells
Keywords: بکساروتن; AP-1; activator protein-1; ATCC; American Type Culture Collection; CDK4; cyclin-dependent kinase 4; CI; combination index; Cmax; maximum concentration; CTCL; cutaneous T cell lymphoma; DMSO; dimethyl sulfoxide; FAM; 6-carboxy-fluorescein; ICn; concentrati